Lumayag, Melchecedic L.

HRN: 05-63-62  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2025
CIPROFLOXACIN 500MG (TAB)
07/01/2025
07/08/2025
PO
500mg
BID
CAP
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: